Anjalee Khemlani

The FDA knows generative AI is on the horizon, but is grappling with how to ensure its safe use in healthcare.

Amazon Pharmacy announced Tuesday its latest move to improve price transparency for pharmacy customers.

The Biden administration is making good on promises to help lower drug costs, though the impact is largely for Medicare patients.

Walgreens faces backlash over misperception of its intent to sell abortion pill in some states.

CVS acquiring Oak Street and Amazon acquiring One Medical are just the latest moves in retail health. But they could have significant future impact.

CVS acquiring Oak Street and Amazon acquiring One Medical are just the latest moves in retail health. But they could have significant future impact.

Seagen is once again an acquisition target this year, pursued by yet another partner, Pfizer. Last year, a deal with Merck fell through over price disagreements.

Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.

Amazon announces a new drug pass for Prime members.

Carbon Health had to slow its growth in response to a cooler market for health care investment this year.